GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE Uses, Dosage, Side Effects and more
GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE is under investigation in clinical trial NCT03081676 (The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea).
| Trade Name | GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE |
| Generic | Gastric inhibitory polypeptide |
| Gastric inhibitory polypeptide Other Names | GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
